Genentech, a member of the Roche group, announced new data on Thursday related to its investigational CD20xCD3 T-cell engaging bispecific antibody, glofitamab, which is intended to treat relapsed or refractory diffuse large B-cell lymphoma (R/R DLBCL).
If you are not happy with the results below please do another search
50 search results for:
Countries have agreed to an initial U.S.-led push to reform the rules around disease outbreaks, known as the International Health Regulations, after early opposition from Africa and others was overcome this week, sources told Reuters on Friday.
The European Union is working on a common purchasing agreement for vaccines and antiviralsagainst monkeypox, as cases of the viral disease usually endemic to Africa gather steam in Europe and beyond.
McCann Health London announces a new leadership line-up in a raft of management promotions as part of the group’s ongoing growth, enabled by last year’s formation of IPG Health.
Countries should take quick steps to contain the spread of monkeypox and share data about their vaccine stockpiles, a senior World Health Organization official said on Friday.
In the months before it acknowledged its first official COVID-19 outbreak, North Korea suddenly imported millions of face masks, 1,000 ventilators, and possibly vaccines from China, trade data released by Beijing showed.
Although cancer screening and diagnosis was hit by the coronavirus pandemic, resulting advances in medical technology and greater diversity in clinical trials could help treatments in the future, an AstraZeneca executive said.
As cases and news of monkeypox spread globally, scientists are investigating the unprecedented outbreak. BioSpace compiled updates about tracking, origins and treatments concerning monkeypox.
On Thursday, Pfizer announced the U.S. Food and Drug Administration granted the company’s combinatorial therapeutic ervogastat/clesacostat Fast Track Designation. The therapeutic combo is intended for the treatment of non-alcoholic steatohepatitis (NASH) with liver fibrosis.
Medtronic plc (NYSE:MDT) and DaVita Inc. (NYSE:DVA) today announced the intent to form a new, independent kidney care-focused medical device company to enhance the patient treatment experience and improve overall outcomes.